NEW YORK, Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage founder and CTO, Patrick J. Treado, PhD, will present a scientific poster describing an innovative diagnostic procedure for the detection of colorectal cancer during the SPEC 2014: Shedding New Light on Disease (SPEC) conference in Krakow, Poland.
Dr. Treado's poster entitled, "Development of in vitro Diagnostics for Detection of Colorectal Cancer Using Raman Molecular Imaging" will be discussed during the conference poster session on Tuesday, August 19, 2014 from 6:30 – 8:00pm. The scientific poster presents the results of a study performed by scientists at ChemImage, in collaboration with urology and gastroenterology clinicians, on the development of in vitro diagnostic (IVD) Raman assays focused on colorectal cancer detection. The results of these ongoing clinical studies will be presented including discussion of the study design, the underlying basis of discrimination and advantages provided by RMI.
"I am very excited to present our findings at 2014 SPEC," said Patrick J. Treado, Chief Technology Officer at ChemImage. "I look forward to sharing the results of our research with thought leaders in the Raman spectroscopy community."
SPEC 2014 is an international conference series aiming to bring together clinicians and scientists who have joined forces in the quest for novel biomedical applications of Infrared and Raman spectroscopy to improve patient care. Due to its unique fingerprinting capability, Raman spectroscopy plays a significant role in histopathology, cytology, biopsy targeting, surgical targets, and treatment monitoring and drug studies. The conference highlights further advances in state of the art and emerging biomedical applications of Raman Spectroscopy, while critically reviewing the challenges in the context of other emerging technologies.
For more information regarding ChemImage's Raman chemical imaging capabilities, contact Patrick Treado at firstname.lastname@example.org.
ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.
ChemImage's headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.
Media Contact: Tifanie Tiberio, ChemImage Corporation, 412-241-7335 ext. 269, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
|SOURCE ChemImage Corporation|
Copyright©2014 PR Newswire.
All rights reserved